PL2720707T3 - Przeciwzapalne produkty farmaceutyczne - Google Patents

Przeciwzapalne produkty farmaceutyczne

Info

Publication number: PL2720707T3
Authority: PL; Poland
Prior art keywords: pharmaceutical products; inflammatory pharmaceutical; inflammatory; products; pharmaceutical
Prior art date: 2011-06-15

Application number

PL12799815T

Other languages

English (en)

Inventor

Angelo P. Consalvo

Nozer M. Mehta

Mauro Perretti

Jesmond DALLI

Original Assignee

Resother Pharma Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-06-15

Filing date

2012-06-15

Publication date

2019-06-28

2012-06-15 Application filed by Resother Pharma Aps filed Critical Resother Pharma Aps

2019-06-28 Publication of PL2720707T3 publication Critical patent/PL2720707T3/pl

Links

230000003110 anti-inflammatory effect Effects 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
229940127557 pharmaceutical product Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Marine Sciences & Fisheries (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL12799815T 2011-06-15 2012-06-15 Przeciwzapalne produkty farmaceutyczne PL2720707T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201161497270P	2011-06-15	2011-06-15
EP12799815.1A EP2720707B1 (en)	2011-06-15	2012-06-15	Anti-inflammatory pharmaceutical products
PCT/US2012/042699 WO2012174397A2 (en)	2011-06-15	2012-06-15	Anti-inflammatory pharmaceutical products
US13/524,381 US9102753B2 (en)	2011-06-15	2012-06-15	Anti-inflammatory pharmaceutical products

Publications (1)

Publication Number	Publication Date
PL2720707T3 true PL2720707T3 (pl)	2019-06-28

Family

ID=47357770

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12799815T PL2720707T3 (pl)	2011-06-15	2012-06-15	Przeciwzapalne produkty farmaceutyczne

Country Status (12)

Country	Link
US (2)	US9102753B2 (pl)
EP (2)	EP3533457B1 (pl)
JP (1)	JP6069663B2 (pl)
CN (1)	CN103764669B (pl)
AU (1)	AU2012271453B2 (pl)
BR (1)	BR112013032088B1 (pl)
CA (1)	CA2839298C (pl)
DK (1)	DK2720707T3 (pl)
ES (1)	ES2712805T3 (pl)
HU (1)	HUE042929T2 (pl)
PL (1)	PL2720707T3 (pl)
WO (1)	WO2012174397A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8377863B2 (en)	2007-05-29	2013-02-19	Unigene Laboratories Inc.	Peptide pharmaceutical for oral delivery
PL2720707T3 (pl)	2011-06-15	2019-06-28	Resother Pharma Aps	Przeciwzapalne produkty farmaceutyczne
ES2774962T3 (es)	2013-03-05	2020-07-23	Enteris Biopharma Inc	Productos farmacéuticos de administración oral
JP6910950B2 (ja)	2015-01-12	2021-07-28	エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓＢｉｏｐｈａｒｍａ，Ｉｎｃ．	固形経口剤形
PL4200319T3 (pl) *	2020-08-21	2025-08-18	Resother Pharma A/S	Preparaty peptydu n-końcowego aneksyny a1 i sposoby
EP4482853A1 (en)	2022-02-23	2025-01-01	Resother Pharma A/S	Annexin a1-derived polypeptide analogues
US20250345392A1 (en)	2022-06-30	2025-11-13	Resother Pharma A/S	Annexin a1 liquid pharmaceutical composition
CN121079101A (zh)	2023-03-13	2025-12-05	雷索特制药股份有限公司	膜联蛋白a1施用方案
EP4680262A1 (en)	2023-03-13	2026-01-21	Resother Pharma A/S	Annexin a1 delayed dosing

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6319685B1 (en)	1984-09-27	2001-11-20	Unigene Laboratories, Inc.	Alpha-amidating enzyme compositions and processes for their production and use
US4708934A (en)	1984-09-27	1987-11-24	Unigene Laboratories, Inc.	α-amidation enzyme
US5789234A (en)	1987-08-14	1998-08-04	Unigene Laboratories, Inc.	Expression systems for amidating enzyme
HUP0001272A3 (en)	1997-04-16	2012-12-28	Unigene Lab Inc	Direct expression of peptides into culture media
US6086018A (en)	1997-12-09	2000-07-11	Mcdonnell Douglas Corporation	Interlocking assembly system for an aircraft cabin
WO2006039621A2 (en) *	2004-10-01	2006-04-13	University Of Medicine And Dentistry Of New Jersey	Novel modification of immunomodulatory protein
US7445911B2 (en)	2004-11-24	2008-11-04	Unigene Laboratories Inc.	Enzymatic reactions in the presence of keto acids
EP1907561B1 (en)	2005-06-24	2013-08-28	Unigene Laboratories, Inc.	Cell lines for expressing enzyme useful in the preparation of amidated products
EP1933883B1 (en)	2005-08-03	2015-10-07	Rq Bioscience, Inc.	Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
AU2005335905C1 (en) *	2005-08-26	2011-12-22	Abbvie Inc.	Therapeutically active alpha-MSH analogues
WO2008121881A2 (en)	2007-03-28	2008-10-09	Research Foundation Of State University Of New York	INHIBITORS OF NF-ϰB ACTIVITY
US8377863B2 (en)	2007-05-29	2013-02-19	Unigene Laboratories Inc.	Peptide pharmaceutical for oral delivery
GB0724953D0 (en)	2007-12-20	2008-01-30	Lytix Biopharma As	Methods of peptide modification
EP2349321B1 (en) *	2008-10-17	2020-04-22	London Health Sciences Centre Research Inc.	Annexin and its use to treat inflammatory disorders
US8940697B2 (en) *	2009-10-16	2015-01-27	Duke University	Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
PL2720707T3 (pl) *	2011-06-15	2019-06-28	Resother Pharma Aps	Przeciwzapalne produkty farmaceutyczne

2012
- 2012-06-15 PL PL12799815T patent/PL2720707T3/pl unknown
- 2012-06-15 HU HUE12799815A patent/HUE042929T2/hu unknown
- 2012-06-15 AU AU2012271453A patent/AU2012271453B2/en active Active
- 2012-06-15 EP EP18212844.7A patent/EP3533457B1/en active Active
- 2012-06-15 EP EP12799815.1A patent/EP2720707B1/en active Active
- 2012-06-15 BR BR112013032088-5A patent/BR112013032088B1/pt active IP Right Grant
- 2012-06-15 WO PCT/US2012/042699 patent/WO2012174397A2/en not_active Ceased
- 2012-06-15 CN CN201280028984.3A patent/CN103764669B/zh active Active
- 2012-06-15 JP JP2014516041A patent/JP6069663B2/ja active Active
- 2012-06-15 CA CA2839298A patent/CA2839298C/en active Active
- 2012-06-15 DK DK12799815.1T patent/DK2720707T3/en active
- 2012-06-15 ES ES12799815T patent/ES2712805T3/es active Active
- 2012-06-15 US US13/524,381 patent/US9102753B2/en active Active
2015
- 2015-07-20 US US14/803,426 patent/US10072055B2/en active Active

Also Published As

Publication number	Publication date
CN103764669A (zh)	2014-04-30
CA2839298A1 (en)	2012-12-20
EP2720707B1 (en)	2018-12-19
EP2720707A2 (en)	2014-04-23
ES2712805T3 (es)	2019-05-14
JP6069663B2 (ja)	2017-02-01
JP2014519526A (ja)	2014-08-14
US9102753B2 (en)	2015-08-11
AU2012271453A1 (en)	2013-12-19
BR112013032088B1 (pt)	2020-11-24
WO2012174397A2 (en)	2012-12-20
US10072055B2 (en)	2018-09-11
BR112013032088A2 (pt)	2016-11-22
CA2839298C (en)	2021-05-18
DK2720707T3 (en)	2019-04-08
AU2012271453B2 (en)	2017-07-06
EP2720707A4 (en)	2015-05-06
WO2012174397A3 (en)	2013-02-28
US20130072446A1 (en)	2013-03-21
HUE042929T2 (hu)	2019-07-29
EP3533457A1 (en)	2019-09-04
CN103764669B (zh)	2017-08-15
EP3533457B1 (en)	2021-08-11
US20150315256A1 (en)	2015-11-05

Publication	Publication Date	Title
AP3864A (en)	2016-10-31	Pharmaceutical composition
SI2776416T1 (sl)	2016-06-30	Farmacevtske spojine
GB201118232D0 (en)	2011-12-07	Pharmaceutical composition
SG10201604667YA (en)	2016-07-28	Pharmaceutical preparation
IL232305B (en)	2019-06-30	Pharmacy preparations
HUE042929T2 (hu)	2019-07-29	Gyulladáscsökkentõ gyógyszerészeti termékek
ZA201308157B (en)	2015-01-28	Pharmaceutical composition
GB201119799D0 (en)	2011-12-28	Pharmaceutical compounds
ZA201403832B (en)	2016-02-24	Pharmaceutical compounds
GB201105298D0 (en)	2011-05-11	Pharmaceutical preparation
GB201118876D0 (en)	2011-12-14	Pharmaceutical compounds
SI2768485T1 (sl)	2015-12-31	Farmacevtska nanosuspenzija
GB201113163D0 (en)	2011-09-14	Pharmaceutical compounds
EP2727593A4 (en)	2014-11-26	PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
GB201222679D0 (en)	2013-01-30	Pharmaceutical combination products
PL2691119T3 (pl)	2019-01-31	Preparat farmaceutyczny
EP2711010A4 (en)	2015-04-15	PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en)	2013-02-28	Pharmaceutical composition
HUP1100445A2 (en)	2013-02-28	Pharmaceutical composition
GB201119796D0 (en)	2011-12-28	Pharmaceutical comopounds
GB201208327D0 (en)	2012-06-27	Anti-inflammatory product
GB201120735D0 (en)	2012-01-11	New pharmaceutical uses
GB201111577D0 (en)	2011-08-24	Pharmaceutical formulations
GB201117359D0 (en)	2011-11-23	Pharmaceutical compounds
GB201105026D0 (en)	2011-05-11	Pharmaceutical compounds